144 related articles for article (PubMed ID: 2969499)
1. Monoclonal antibody-ricin conjugate cytotoxic to cells expressing the common acute lymphoblastic leukemia antigen (CALLA).
Pelham JM; Meyer BF; Herrmann RP; Davis RE; Raphael CL; Kraft N; Atkins RC
Pathology; 1987 Apr; 19(2):124-30. PubMed ID: 2969499
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
3. Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6.
Hara H; Luo Y; Haruta Y; Seon BK
Cancer Res; 1988 Aug; 48(16):4673-80. PubMed ID: 2969282
[TBL] [Abstract][Full Text] [Related]
4. An immunotoxin with therapeutic potential in T cell leukemia: WT1-ricin A.
Myers CD; Thorpe PE; Ross WC; Cumber AJ; Katz FE; Tax W; Greaves MF
Blood; 1984 May; 63(5):1178-85. PubMed ID: 6370334
[TBL] [Abstract][Full Text] [Related]
5. [Characterization of murine monoclonal antibodies against the common acute leukemia antigen (CALLA)].
Seifert M; Eichler W; Fiebig H
Allerg Immunol (Leipz); 1990; 36(4):267-76. PubMed ID: 2151502
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of monoclonal antibody DF3 conjugated with ricin as a specific immunotoxin for in vitro purging of human bone marrow.
Tondini C; Pap SA; Hayes DF; Elias AD; Kufe DW
Cancer Res; 1990 Feb; 50(4):1170-5. PubMed ID: 2404589
[TBL] [Abstract][Full Text] [Related]
7. Standardization of monoclonal antibodies for use in autologous bone marrow transplantation for common acute lymphoblastic leukemia.
Bradstock KF; Favaloro EJ; Kabral A; Kerr A; Prendergast M; Berndt MC; Hughes WG; Zola H; Krishnan R; Haylock D
Pathology; 1986 Apr; 18(2):197-205. PubMed ID: 2945154
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the galactose-binding sites of ricin by its linkage to antibody. Specific cytotoxic effects of the conjugates.
Thorpe PE; Ross WC; Brown AN; Myers CD; Cumber AJ; Foxwell BM; Forrester JT
Eur J Biochem; 1984 Apr; 140(1):63-71. PubMed ID: 6608447
[TBL] [Abstract][Full Text] [Related]
9. Somatic cell mutants resistant to ricin, diphtheria toxin, and to immunotoxins.
Goldmacher VS; Anderson J; Schulz ML; Blättler WA; Lambert JM
J Biol Chem; 1987 Mar; 262(7):3205-9. PubMed ID: 2950096
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo cytotoxic activity of anti-human leukemia monoclonal antibodies SN5c and SN6 daunorubicin conjugates.
Biddle WC; Haruta Y; Seon BK; Henderson ES; Sarcione EJ
Leuk Res; 1989; 13(8):699-707. PubMed ID: 2529399
[TBL] [Abstract][Full Text] [Related]
11. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermia potentiates the activity of immunotoxin conjugates against common acute lymphoblastic leukaemia cells in vitro.
Herrmann RP; Pelham JM; Raphael CL; Meyer BF; Davis RE
Ann N Y Acad Sci; 1987; 511():428-35. PubMed ID: 2964219
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody to common acute lymphoblastic leukemia antigen (CALLA) and its expression on several human tumor cell lines.
Park WS; Hwang TS; Kim TJ; Park CS; Bae YM; Park SH; Lee SK
J Korean Med Sci; 1992 Jun; 7(2):147-53. PubMed ID: 1388026
[TBL] [Abstract][Full Text] [Related]
14. An immunotoxin for immunologic manipulation of marrow ex vivo in autologous transplantation for common acute lymphoblastic leukemia.
Herrmann R; Pelham J; Meyer B; Davis R; Raphael C; Kraft N; Atkins R
Transplant Proc; 1986 Apr; 18(2):278-80. PubMed ID: 2938314
[No Abstract] [Full Text] [Related]
15. Discrepancy between flow cytometric analyses of CALLA using two monoclonal antibodies.
Fried J; Perez AG; Shimazaki C; Clarkson BD
Exp Cell Biol; 1987; 55(6):322-30. PubMed ID: 2453381
[TBL] [Abstract][Full Text] [Related]
16. Ricin A immunotoxins of IgG and Fab of anti-CALLA monoclonal antibody: effect of water soluble long-chain SPDP on conjugate yield, immunoselectivity and cytotoxicity.
Woo BH; Lee JT; Lee KC
Arch Pharm Res; 1994 Dec; 17(6):452-7. PubMed ID: 10319157
[TBL] [Abstract][Full Text] [Related]
17. Thy 1.2+ leukemia cells eradicated from in vitro leukemia-bone marrow cell mixtures by antibody-toxin conjugates.
Colombatti M; Colombatti A; Blythman HE; Bron C
J Natl Cancer Inst; 1984 May; 72(5):1095-9. PubMed ID: 6585586
[TBL] [Abstract][Full Text] [Related]
18. Immunocytological and immunochemical analysis on the common acute lymphoblastic leukemia antigen (CALLA): evidence that CALLA on ALL cells and granulocytes are structurally related.
Fujimoto J; Ishimoto K; Kiyokawa N; Tanaka S; Ishii E; Hata J
Hybridoma; 1988 Jun; 7(3):227-36. PubMed ID: 2969365
[TBL] [Abstract][Full Text] [Related]
19. Binding and cytotoxic effect of ricin toxin on multivalent hybrid antibody-coated target cells.
Laky M; Mota G; Moraru I; Ghetie V
Immunol Lett; 1987 Jan; 14(2):127-32. PubMed ID: 3495487
[TBL] [Abstract][Full Text] [Related]
20. Cultured marrow stromal cells express common acute lymphoblastic leukaemia antigen (CALLA): implications for marrow transplantation.
Keating A; Whalen CK; Singer JW
Br J Haematol; 1983 Dec; 55(4):623-8. PubMed ID: 6200132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
